Bayesian Capital Management’s Merit Medical Systems MMSI Stock Holding History

Bayesian Capital Management’s Portfolio MMSI Stock Details MMSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,421	Closed	-$236K	–	927
2023 Q3	$236K	Buy	+3,421	New	+$246K	0.03%	522
2023 Q2	–	Sell	-9,600	Closed	-$710K	–	966
2023 Q1	$710K	Buy	+9,600	New	+$674K	0.09%	307
2020 Q4	–	Sell	-5,996	Closed	-$261K	–	592
2020 Q3	$261K	Buy	+5,996	New	+$271K	0.06%	377
2019 Q2	–	Sell	-4,696	Closed	-$290K	–	620
2019 Q1	$290K	Sell	4,696 -3,000	-39%	-$170K	0.06%	393
2018 Q4	$430K	Sell	7,696 -7,300	-49%	-$434K	0.09%	322
2018 Q3	$922K	Buy	14,996 +10,300	+219%	+$592K	0.15%	198
2018 Q2	$240K	Buy	+4,696	New	+$233K	0.05%	472
2017 Q4	–	Sell	-11,306	Closed	-$479K	–	656
2017 Q3	$479K	Buy	11,306 +4,800	+74%	+$193K	0.11%	274
2017 Q2	$248K	Buy	+6,506	New	+$217K	0.09%	332

Other funds holding MMSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bayesian Capital Management's MMSI Position: Q4 2023 in Review

Bayesian Capital Management sold out of Merit Medical Systems (MMSI) in Q4 2023, closing a stake of 3,421 shares — an estimated $236K sold.

Bayesian Capital Management first reported a position in MMSI in Q2 2017 and held it in 9 quarters. The position peaked at $922K in Q3 2018. 289 funds tracked by Wall St. Rank hold MMSI as of Q4 2023.

Bayesian Capital Management reported no remaining Merit Medical Systems position as of Q4 2023 after selling out during the quarter.
Bayesian Capital Management sold 3,421 Merit Medical Systems shares in Q4 2023, an estimated $236K.
Bayesian Capital Management first reported a position in Merit Medical Systems in Q2 2017 and held it in 9 quarters.
Bayesian Capital Management's Merit Medical Systems position peaked at $922K in Q3 2018.
289 funds tracked by Wall St. Rank held Merit Medical Systems as of Q4 2023.

Based on Bayesian Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.